25-49
Investigation of the Mechanisms of Positive Inotropic Effect of (–)–Epigallocatechin 3–O–gallate
Authors: Shunkor S. Khushmatov, Pulat B. Usmanov, Khurshida K. Nadjimova, Ulugbek G. Gayibov, Nodira G. Abdulladjanova
Number of views: 468
The aim of the present study was to determine mechanism of the inotropic effect of (–)–epigallocatechin 3–O–gallate (EGCG) in the rat myocardium. EGCG was isolated from seeds grapes (Vitis vinifera L.). Isometric tension forces of preparations of isolated papillary muscle were recorded using a force transducer (Type F30/Model D–79232; Hugo Sachs Elektronik, Germany). EGCG (15–100 µmol.L–1) showed dose–dependent a positive inotropic effects in rat papillary muscle contractility. The condition where the maximal effected concentration (150 µmol.L–1) of EGCG, the isometric developed force of papillary muscle preparation was decreased from 67,5±6,2 % in comparison with the control group (p<0,05; n=3–4). In these conditions, the EC50 value (the values of concentration for 50 % of the maximal effect) EGCG was 22,39 µmol.L–1 or pD2 (–logEC50)=4,652. In the experiments lead by means of specifical experimental technique of a mechanical stretching of myocardium showed, that EGCG (150 µmol.L–1) was increased amplitudes II phase (SFR, slow force response) from 33,7±4,9 % in comparison with the control group. Pretreatment with amiloride hydrochlorid (1 mmol.L–1), a nonselective inhibitor of NHE–1, attenuated the positive inotropic effect of EGCG in the isolated rat papillary muscles. In conclusion, the present study demonstrates that, the positive inotropic effect of EGCG (15–150 µmol.L–1) in isometrically contracting papillary muscles seems to be mediated by NHE–1 [Nа+]in NCX1 [Са2+]in pathway. These data may serve as a basis for further detailed pharmacological mechanism of action of this compound.